These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11347040)

  • 1. [Hyper-remnant-like particles (RLP) lipoproteinemia].
    Tanaka A; Ai M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():107-11. PubMed ID: 11347040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Method for remnant lipoproteins--quantitative analysis of serum remnant-like particle cholesterol (RLP-C)].
    Nambu S
    Nihon Rinsho; 1999 Dec; 57(12):2740-4. PubMed ID: 10638206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [RLP-C (remnant-like particle cholesterol)].
    Iwashima Y
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():262-8. PubMed ID: 9513427
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.
    Nakamura N; Hamazaki T; Kobayashi M; Ohta M; Okuda K
    In Vivo; 1998; 12(3):311-4. PubMed ID: 9706476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of high remnant-like lipoproteins on the function of peripheral arterial endothelium in patients with hyperlipidemia and normolipidemia: estimation using Doppler flow analysis].
    Funada J; Sekiya M; Otani T; Watanabe K; Akutsu H
    J Cardiol; 2001 May; 37(5):267-76. PubMed ID: 11392896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of serum remnant-like lipoprotein particle-triglyceride (RLP-TG) and RLP-TG/total TG ratio using highly sensitive triglyceride assay reagent.
    Nakano T; Tokita Y; Nagamine T; Tanaka A; Okazaki M; Yatsuzuka S; Tamei N; Shimomura Y; Ando Y; Akamatsu S; Fujita MQ; Nakajima K
    Clin Chim Acta; 2011 Jan; 412(1-2):71-8. PubMed ID: 20951691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle size of apoB-48 carrying lipoproteins in remnant lipoproteins isolated from postprandial plasma.
    Nakano T; Tanaka A; Okazaki M; Tokita Y; Nagamine T; Nakajima K
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):57-64. PubMed ID: 21098545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperlipidemia in diabetes mellitus].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():143-51. PubMed ID: 11347047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperlipoproteinemias and their dietetic treatment].
    Oriente P; Di Marino L
    Minerva Med; 1973 Apr; 64(24):1259-66. PubMed ID: 4707409
    [No Abstract]   [Full Text] [Related]  

  • 10. [Remnant hyperlipidemia].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():112-8. PubMed ID: 11347041
    [No Abstract]   [Full Text] [Related]  

  • 11. Remnant-like lipoprotein particle level and insulin resistance are associated with in-stent restenosis in patients with stable angina.
    Kato T; Inoue T; Inagaki H; Hashimoto S; Hikichi Y; Tanaka A; Isobe M; Node K
    Coron Artery Dis; 2007 Jun; 18(4):319-22. PubMed ID: 17496497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyper-remnant lipoproteinemia].
    Doi H; Matsumura T; Abe K
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():360-5. PubMed ID: 17824057
    [No Abstract]   [Full Text] [Related]  

  • 13. A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.
    Rosenson RS
    Curr Atheroscler Rep; 2009 May; 11(3):161-4. PubMed ID: 19361346
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary diacylglycerol in a typical meal suppresses postprandial increases in serum lipid levels compared with dietary triacylglycerol.
    Tomonobu K; Hase T; Tokimitsu I
    Nutrition; 2006 Feb; 22(2):128-35. PubMed ID: 16459225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remnant hyperlipidemia and gene polymorphism].
    Tada N
    Nihon Rinsho; 1999 Dec; 57(12):2789-94. PubMed ID: 10638214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
    Okamoto H; Miyai A; Sasase T; Furukawa N; Matsushita M; Nakano T; Nakajima K
    Clin Chim Acta; 2007 Jan; 375(1-2):92-8. PubMed ID: 16859664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipoproteinemias, diet and drug therapy. Risk of arteriosclerosis and the lipoproteins].
    Schwandt P
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):447-8. PubMed ID: 6769012
    [No Abstract]   [Full Text] [Related]  

  • 18. Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.
    Hegele RA; Pollex RL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1224-7. PubMed ID: 17522394
    [No Abstract]   [Full Text] [Related]  

  • 19. Dietary and drug treatment of hyperlipoproteinemia.
    Mordasini R; Oster P; Riesen W
    Ric Clin Lab; 1982; 12(1):117-25. PubMed ID: 7046017
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter by Singh et al regarding article, "Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the GOLDN study".
    Singh P; Di Napoli M; Singh M
    Circ Cardiovasc Genet; 2011 Feb; 4(1):e5; author reply e6. PubMed ID: 21325156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.